SCHEMBL11918192

SCHEMBL11918192

O=C(CCCN1C(=O)/C(=C/c2cccc(Br)c2)SC1=S)Nc1ccccc1O

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDX3X O00571 5/20 0.90
▸ MAPT P10636 8/20 0.82
▸ SMN1; SMN2 Q16637 7/20 0.82
▸ HTT P42858 6/20 0.82
▸ MEN1 O00255 6/20 0.82
▸ KMT2A Q03164 6/20 0.82
▸ MAPK1 P28482 4/20 0.82
▸ LMNA P02545 4/20 0.72
▸ PAX8 Q06710 3/20 0.72
▸ NPC1 O15118 1/20 0.69
▸ POLB P06746 1/20 0.69
▸ L3MBTL1 Q9Y468 2/20 0.65
▸ PKM P14618 1/20 0.65
▸ ALDH1A1 P00352 2/20 0.62
▸ TDP1 Q9NUW8 1/20 0.62
▸ GAA P10253 1/20 0.62
▸ ATM Q13315 1/20 0.62
▸ SENP8 Q96LD8 1/20 0.62
▸ SENP7 Q9BQF6 1/20 0.62
▸ SENP6 Q9GZR1 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11899367 0.94 DDX3X (1.00) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL11899368 0.94 DDX3X (1.00) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL11899366 0.94 DDX3X (1.00) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL11918194 0.85 DDX3X (0.90) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL11913685 0.85 MEN1 (0.88) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL11913686 0.84 DDX3X (0.80) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL12008750 0.84 DDX3X (0.80) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL12008797 0.83 SENP8 (0.71) DDX3XMAPTSMN1; SMN2HTTKMT2A
SCHEMBL1655161 0.83 DDX3X (1.00) DDX3XMAPTSMN1; SMN2HTTMEN1
SCHEMBL1655158 0.83 DDX3X (1.00) DDX3XMAPTSMN1; SMN2HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 — — US disclosed
WO-2011039735-A2 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2011-04-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B DDX3X 1/4885MAPT 4074/4885SMN1; SMN2 1751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback